STUELPNAGEL JOHN R - Insider Non-Derivative Transactions at 10x Genomics, Inc. (TXG) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 11, 2024, STUELPNAGEL JOHN R's relationship to 10x Genomics, Inc. (TXG) is Director, and currently has 344,250 shares of Class A Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TXG insiders.
Data Source: SEC.
STUELPNAGEL JOHN R - Insider Non-Derivative Transactions of TXG Class A Common Stock
STUELPNAGEL JOHN R - Insider Non-Derivative Transactions at TXG
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 12, 2024 | Acquisition -- (Class A Common Stock) | 8649 | 0 | 344250 |
| Jun 15, 2023 | Acquisition -- (Class A Common Stock) | 1865 | 0 | 335601 |
| Jun 6, 2023 | Sell -- (Class A Common Stock) | 10000 | 54.89 | 333736 |